Crystalline form of 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone
TWI632133B
Crystalline form of 3-z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone for effectively treating angiogenic ocular diseases
CN110072849A
The crystal form of 3-Z- [1- (4- (N- ((4- thyl-piperazin -1- base)-first carbonyl)-N- Methyl-amino)-phenylamino) -1- phenyi-methylene] -6- methoxycarbonyl group -2- dihydroindole ketone
US2018170979A1
Fusion proteins for inhibiting angiogenesis
TW201936187A
Use of ophthalmic formulations of tyrosine kinase inhibitors
MX2017013483A
Compounds and their use as bace1 inhibitors.
CN107108757A
The fusion protein of ligand binding domain comprising VEGF and PDGF
